Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Immunotherapy × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 14 Carcinoma, Hepatocellular 6 Melanoma 5 Squamous Cell Carcinoma of Head and Neck 4 Lung Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Triple Negative Breast Neoplasms 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm, Residual 2 Neoplasm Metastasis 2 Hyperthermia 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Uveal Melanoma 1 Turcot syndrome 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Recurrence 1 Radiation Pneumonitis 1 Prostatic Neoplasms 1 Pancreatic Cancer Liver Metastases 1 Neoplasms, Glandular and Epithelial 1

Interventions

Temozolomide 55 Bevacizumab 51 Radiotherapy 34 Radiosurgery 24 Carboplatin 20 pembrolizumab 15 Irinotecan 14 Etoposide 14 Nivolumab 13 Cisplatin 13 Carmustine 13 Cyclophosphamide 12 Pemetrexed 11 Ipilimumab 11 Erlotinib Hydrochloride 11 Magnetic Resonance Spectroscopy 10 Surgical Procedures, Operative 9 Lapatinib 9 Capecitabine 9 Topotecan 8 Thalidomide 8 Aminolevulinic Acid 8 Lomustine 7 Gefitinib 7 Filgrastim 7 trametinib 6 osimertinib 6 encorafenib 6 binimetinib 6 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04650490 2023-03-02

STICk-IM-NSCLC

Duke University

Phase 2 Withdrawn

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡